Aurelie Chauffour
Paris, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Bedaquiline Activity against Leprosy.
Journal: The New England journal of medicine
Published: June 04, 2025
Alpibectir-Ethionamide combination (AlpE) for the treatment of tuberculosis.
Journal: Nature communications
Published: March 07, 2025
Unprecedented in vivo activity of telacebec against Mycobacterium leprae.
Journal: PLoS neglected tropical diseases
Published: November 19, 2024
The role of cytochrome bc1 inhibitors in future tuberculosis treatment regimens.
Journal: Nature communications
Published: November 04, 2024
Levofloxacin activity at increasing doses in a murine model of fluoroquinolone-susceptible and -resistant tuberculosis.
Journal: Antimicrobial agents and chemotherapy
Published: October 16, 2024
Minimal effective dose of bedaquiline administered orally and activity of a long acting formulation of bedaquiline in the murine model of leprosy.
Journal: PLoS neglected tropical diseases
Published: May 15, 2023
Drug resistance in leprosy: An update following 70years of chemotherapy.
Journal: Infectious diseases now
Published: January 25, 2022
Lipophilic quinolone derivatives: Synthesis and in vitro antibacterial evaluation.
Journal: Bioorganic & medicinal chemistry letters
Published: August 16, 2021
A systematic review of Mycobacterium leprae DNA gyrase mutations and their impact on fluoroquinolone resistance.
Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
Published: January 19, 2021
Population Genomics of Mycobacterium leprae Reveals a New Genotype in Madagascar and the Comoros.
Journal: Frontiers in microbiology
Published: December 30, 2019
Fully weekly antituberculosis regimen: a proof-of-concept study.
Journal: The European respiratory journal
Published: December 30, 2019
Last Updated: 09/26/2026